The CARDE-B Scoring System Predicts 30-Day Mortality After Revision Total Joint Arthroplasty | Zendy

Micheal Raad | Zendy; Raj M. Amin | Zendy; Varun Puvanesarajah | Zendy; Farah N. Musharbash | Zendy; Sandesh S. Rao | Zendy; Matthew J. Best | Zendy; Derek F. Amanatullah | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The CARDE-B Scoring System Predicts 30-Day Mortality After Revision Total Joint Arthroplasty

Author(s) -

Micheal Raad,

Raj M. Amin,

Varun Puvanesarajah,

Farah N. Musharbash,

Sandesh S. Rao,

Matthew J. Best,

Derek F. Amanatullah

Publication year - 2021

Publication title -

journal of bone and joint surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.634

H-Index - 260

eISSN - 1058-2436

pISSN - 0021-9355

DOI - 10.2106/jbjs.20.00969

Subject(s) - medicine , perioperative , body mass index , logistic regression , dialysis , arthroplasty , malnutrition , heart failure , surgery , emergency medicine

There exists a substantial risk of having a perioperative complication after revision total joint arthroplasty (TJA). The complex shared decision-making between surgeon and patient would benefit from a high-fidelity tool to identify patients at risk for mortality after revision TJA. Therefore, we developed the CARDE-B score. CARDE-B is an acronym for congestive heart failure, albumin or malnutrition (<3.5 mg/dL), renal failure on dialysis, dependence for daily living, elderly (>65 years of age), and body mass index <25 kg/m2. We developed and validated the CARDE-B score to determine the risk of death within 30 days of a revision TJA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research